Ørsted Valuation
Is ORSTEC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Future Cash Flow Value
Significantly Below Future Cash Flow Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Future Cash Flow Value
What is the Fair Price of ORSTEC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Ultimate guide to DCF valuation for stock investing
Learn how to determine fair value like the best investors in the world.
Below Future Cash Flow Value: ORSTEC (DKK145.23) is trading above our estimate of future cash flow value (DKK77.13)
Significantly Below Future Cash Flow Value: ORSTEC is trading above our estimate of future cash flow value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ORSTEC?
Key metric: As ORSTEC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ORSTEC's PS Ratio? | |
|---|---|
| PS Ratio | 2.6x |
| Sales | DKK 71.19b |
| Market Cap | DKK 187.06b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.9x |
| Enterprise Value/EBITDA | 13.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ORSTEC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.8x | ||
DRX Drax Group | 0.5x | -8.47% | UK£3.1b |
SSE SSE | 2.8x | 9.63% | UK£29.1b |
CNA Centrica | 0.4x | -0.20% | UK£8.6b |
NG. National Grid | 3.5x | 10.67% | UK£61.3b |
ORSTEC Ørsted | 2.6x | 4.61% | DKK 187.1b |
Price-To-Sales vs Peers: ORSTEC is expensive based on its Price-To-Sales Ratio (2.6x) compared to the peer average (1.8x).
Historical Price to Sales Ratio
Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.
Fetching historical data
Price to Sales Ratio vs Industry
How does ORSTEC's PS Ratio compare vs other companies in the European Renewable Energy Industry?
| 14 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 14 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: ORSTEC is good value based on its Price-To-Sales Ratio (2.6x) compared to the European Renewable Energy industry average (2.7x).
Price to Sales Ratio vs Fair Ratio
What is ORSTEC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.6x |
| Fair PS Ratio | 2.1x |
Price-To-Sales vs Fair Ratio: ORSTEC is expensive based on its Price-To-Sales Ratio (2.6x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | DKK 145.23 | DKK 143.08 -1.47% | 12.06% | DKK 184.00 | DKK 110.00 | n/a | 24 |
| Jan ’27 | n/a | DKK 137.39 0% | 13.95% | DKK 184.00 | DKK 110.00 | n/a | 23 |
| Dec ’26 | DKK 133.93 | DKK 133.08 -0.63% | 12.97% | DKK 170.00 | DKK 105.60 | n/a | 21 |
| Nov ’26 | DKK 116.25 | DKK 139.31 +19.84% | 28.22% | DKK 300.00 | DKK 105.60 | n/a | 21 |
| Oct ’26 | DKK 118.53 | DKK 156.77 +32.27% | 39.52% | DKK 320.00 | DKK 105.60 | n/a | 17 |
| Sep ’26 | DKK 200.00 | DKK 256.08 +28.04% | 22.78% | DKK 375.00 | DKK 175.00 | n/a | 19 |
| Aug ’26 | DKK 311.10 | DKK 315.93 +1.55% | 17.32% | DKK 430.00 | DKK 211.00 | n/a | 23 |
| Jul ’26 | DKK 272.90 | DKK 310.50 +13.78% | 17.22% | DKK 430.00 | DKK 211.00 | n/a | 23 |
| Jun ’26 | DKK 268.70 | DKK 310.28 +15.47% | 17.36% | DKK 430.00 | DKK 211.00 | n/a | 23 |
| May ’26 | DKK 261.40 | DKK 344.95 +31.96% | 13.74% | DKK 430.00 | DKK 239.95 | n/a | 23 |
| Apr ’26 | n/a | DKK 361.71 0% | 11.30% | DKK 460.00 | DKK 300.00 | n/a | 23 |
| Mar ’26 | DKK 327.20 | DKK 364.32 +11.35% | 12.18% | DKK 460.00 | DKK 300.00 | n/a | 23 |
| Feb ’26 | DKK 265.40 | DKK 397.97 +49.95% | 13.40% | DKK 518.00 | DKK 300.00 | DKK 145.23 | 23 |
| Jan ’26 | DKK 324.75 | DKK 452.39 +39.30% | 10.84% | DKK 540.00 | DKK 365.00 | n/a | 23 |
| Dec ’25 | DKK 397.65 | DKK 463.96 +16.67% | 8.98% | DKK 540.00 | DKK 390.00 | DKK 133.93 | 23 |
| Nov ’25 | DKK 411.50 | DKK 466.52 +13.37% | 9.99% | DKK 540.00 | DKK 385.00 | DKK 116.25 | 23 |
| Oct ’25 | DKK 445.40 | DKK 464.42 +4.27% | 9.30% | DKK 540.00 | DKK 385.00 | DKK 118.53 | 24 |
| Sep ’25 | DKK 394.05 | DKK 453.88 +15.18% | 11.47% | DKK 550.00 | DKK 360.00 | DKK 200.00 | 24 |
| Aug ’25 | DKK 409.90 | DKK 456.33 +11.33% | 11.61% | DKK 550.00 | DKK 360.00 | DKK 311.10 | 24 |
| Jul ’25 | DKK 375.90 | DKK 456.75 +21.51% | 11.77% | DKK 560.00 | DKK 360.00 | DKK 272.90 | 24 |
| Jun ’25 | DKK 415.80 | DKK 454.63 +9.34% | 11.96% | DKK 560.00 | DKK 360.00 | DKK 268.70 | 24 |
| May ’25 | n/a | DKK 453.17 0% | 11.86% | DKK 560.00 | DKK 360.00 | DKK 261.40 | 24 |
| Apr ’25 | DKK 385.65 | DKK 441.78 +14.56% | 13.05% | DKK 560.00 | DKK 340.00 | n/a | 25 |
| Mar ’25 | DKK 377.85 | DKK 440.18 +16.50% | 13.60% | DKK 560.00 | DKK 340.00 | DKK 327.20 | 25 |
| Feb ’25 | n/a | DKK 432.17 0% | 15.00% | DKK 600.00 | DKK 305.00 | DKK 265.40 | 24 |

Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/01 11:43 |
| End of Day Share Price | 2026/01/29 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ørsted A/S is covered by 42 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Virginia Sanz de Madrid Gross | Banco Santander |
| Alejandro Conde Fraisoli | Banco Santander |